Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001627:Bethanidine / Q000627:therapeutic use*; D003647:Debrisoquin / Q000627:therapeutic use*; D003967:Diarrhea / Q000139:chemically induced; D006145:Guanethidine / Q000627:therapeutic use*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007022:Hypotension / Q000139:chemically induced; D007546:Isoquinolines / Q000627:therapeutic use*; D005082:Physical Exertion
D000959:Antihypertensive Agents; D006146:Guanidines; D007546:Isoquinolines; D001627:Bethanidine; D003647:Debrisoquin; D006145:Guanethidine